Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Journal of Child and Adolescent Psychopharmacology|December 26, 2008
A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatmentW Burleson DavissJournal of Child and Adolescent Psychopharmacology|May 15, 2004
A chart review of cyproheptadine for stimulant-induced weight lossW Burleson Daviss, John ScottJournal of Child and Adolescent Psychopharmacology|January 19, 2012
Does comorbid depression predict subsequent adverse life events in youth with attention-deficit/hyperactivity disorders?W Burleson Daviss, Rasim DilerJournal of Attention Disorders|July 24, 2012
Suicidal behaviors in adolescents with ADHD: associations with depressive and other comorbidity, parent-child conflict, trauma exposure, and impairmentW Burleson Daviss, Rasim S DilerJournal of Abnormal Child Psychology|April 2, 2009
Associations of lifetime depression with trauma exposure, other environmental adversities, and impairment in adolescents with ADHDW Burleson Daviss, Rasim S Diler, Boris BirmaherExpert Review of Neurotherapeutics|October 9, 2009
Bupropion for attention deficit hyperactivity and comorbid disordersW Burleson Daviss, Raymond J Pan, James M PerelJournal of Child and Adolescent Psychopharmacology|June 28, 2008
Does pharmacotherapy for attention-deficit/hyperactivity disorder predict risk of later major depression?W Burleson Daviss, Boris Birmaher, Rasim S Diler, et al.Journal of Affective Disorders|February 6, 2007
Differentiating major depressive disorder in youths with attention deficit hyperactivity disorderRasim Somer Diler, W Burleson Daviss, Adriana Lopez, et al.Journal of Child Psychology and Psychiatry, and Allied Disciplines|August 26, 2006
Criterion validity of the Mood and Feelings Questionnaire for depressive episodes in clinic and non-clinic subjectsW Burleson Daviss, Boris Birmaher, Nadine A Melhem, et al.Journal of the American Academy of Child and Adolescent Psychiatry|January 10, 2008
Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomesDonna R Palumbo, Floyd R Sallee, William E Pelham, et al.Pageof 2